CRIS stock forecast
Our latest prediction for Curis Inc's stock price was made on the Jan. 31, 2022 when the stock price was at 3.19$.
In the short term (2weeks), CRIS's stock price should outperform the market by 2.18%. During that period the price should oscillate between -11.56% and +23.96%.
In the medium term (3months), CRIS's stock price should outperform the market by 2.21%. During that period the price should oscillate between -41.69% and +54.24%.
Get email alertsCreate a solid portfolio with CRIS
About Curis Inc
curis is a publicly-traded biotechnology company (nasdaq: cris) focused on the development and commercialization of innovative drug candidates for the treatment of human cancers. curis’s pipeline of drug candidates includes cudc-907, which is currently being investigating in clinical trials in patients with relapsed or refractory diffuse large b-cell lymphoma with alterations in the myc oncogene. curis is also engaged in a broad collaboration with aurigene in the areas of immuno-oncology and precision oncology. as part of this collaboration, curis has exclusive licenses to oral small molecule antagonists of the pd1 and vista pathways, including pdl1/vista antagonist ca-170, and oral small molecule antagonists of the pd1 and tim3 pathways, including pdl1/tim3 antagonist ca-327, as well as to molecules designed to inhibit the irak4 kinase, including ca-4948. ca-170 is currently undergoing testing in a phase 1 trial in patients with advanced solid tumors and lymphomas. ca-4948 is currentl
At the moment the company generates 11M USD in revenues.
On its last earning announcement, the company reported a loss of -0.44$ per share.
The book value per share is 0.21$
Three months stock forecastJan. 31, 2022
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
11M | 95.00% | -36M | -339.50% | -39M | -0.44 | - | - | 85M | 0.21 | -35M | -1M | -35M |